Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a special dressing make skin grafts unnecessary for burns?

NCT ID NCT05462860

Symptom relief Sponsor: The Metis Foundation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a special wound dressing called Suprathel can help partial-thickness burns heal without needing a skin graft. Adults with burns covering at least 2% of their body will receive either Suprathel or standard care. The study looks at how many people avoid grafting, as well as pain, infection, scarring, and healing time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Suprathel, a synthetic wound dressing
What this could lead to
If effective, Suprathel could reduce the need for skin grafting in burn patients, potentially easing pain, lowering infection risk, and improving scar outcomes.
What could go wrong
This is a small early-stage trial, so results may not apply broadly. The dressing may not outperform standard care, and individual healing varies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 21 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or Female ≥18 years and ≤75 years * Acute partial thickness burns by friction, contact, scalding from hot liquids and flame * TBSA total ≥2 %; burn treatment region of interest: all areas with partial-thickness burns excluding face, neck, scalp, and feet * TBSA 3rd ≤5 % (not to be included as burn treatment region of interest) * Subject is able and willing to sign Informed Consent or via legally authorized representative Exclusion Criteria: * Study Wound due to electrical, radioactive, or frostbite-related injury * Infection of wounds in the study area at admission per Investigator or treating physician discretion * Pregnancy/lactation * Subjects who are unable to follow the protocol or who are likely to be non-compliant * Participation in an active treatment arm of a burn wound related interventional study within 90 days of Screening Visit or during the study * Prisoners * Life expectancy less than 6 months * Subjects who are receiving steroids, chronic anticoagulants, or immune suppressive treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burns are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

burn injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Burns Wound of skin

Contacts and locations

Locations

  • North Carolina Jaycee Burn Center

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.